Drug Approval | September 19, 2025
FDA completes inspection of Indoco’s API manufacturing facility at Patalganga with zero observations
The inspection concluded with zero form 483 observations
The inspection concluded with zero form 483 observations
The conference stressed a multi-dimensional approach required to address Antimicrobial Resistance (AMR), focusing on the right approach and strengthening awareness
Goyal reaffirmed the government’s commitment to facilitating market access, reducing trade barriers, and ensuring that Indian exporters remain globally competitive
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
The complex four-hour surgery was performed by a multidisciplinary team of doctors
The conference will explore the path to India’s first billion-dollar drug, evolution towards value-based healthcare, biotech breakthroughs, and the role of AI and LLMs in care delivery
Apollo has also announced plans to add over 4,300 beds in the next five years with an investment of over Rs. 7,600 crore
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Most recently he served as Chief Operating Officer at Bharat Serums and Vaccines
Subscribe To Our Newsletter & Stay Updated
